|
1
|
Li L, Wang G, Li N, Yu H, Si J and Wang J:
Identification of key genes and pathways associated with obesity in
children. Exp Ther Med. 14:1065–1073. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shore SA and Fredberg JJ: Obesity, smooth
muscle, and airway hyperresponsiveness. J Allergy Clin Immunol.
115:925–927. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
McClean KM, Kee F, Young IS and Elborn JS:
Obesity and the lung: 1. Epidemiology. Thorax. 63:649–654. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Beuther DA and Sutherland ER: Overweight,
obesity, and incident asthma: A meta-analysis of prospective
epidemiologic studies. Am J Respir Crit Care Med. 175:661–666.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang S, Yang J, Zheng R, Jiang L, Wei Y
and Liu G: VanWyk-grumbach syndrome in a male pediatric patient: A
rare case report and literature review. Exp Ther Med. 13:1151–1154.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Leynaert B, Sunyer J, Garcia-Esteban R,
Svanes C, Jarvis D, Cerveri I, Dratva J, Gislason T, Heinrich J,
Janson C, et al: Gender differences in prevalence, diagnosis and
incidence of allergic and non-allergic asthma: A population-based
cohort. Thorax. 67:625–631. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shore SA, Schwartzman IN, Mellema MS,
Flynt L, Imrich A and Johnston RA: Effect of leptin on allergic
airway responses in mice. J Allergy Clin Immunol. 115:103–109.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dixon AE and Poynter ME: Mechanisms of
asthma in obesity. pleiotropic aspects of obesity produce distinct
asthma phenotypes. Am J Respir Cell Mol Biol. 54:601–608. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hwang SJ, Kim JH, Shim JW, Kim DS, Jung
HL, Park MS, Lee WY, Kim SY and Shim JY: Peroxisome
proliferator-activated receptor-gamma expression in the lung tissue
of obese rats. Yonsei Med J. 52:495–501. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Harper JW and Zisman TL: Interaction of
obesity and inflammatory bowel disease. World J Gastroenterol.
22:7868–7881. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nawrocki AR and Scherer PE: The delicate
balance between fat and muscle: Adipokines in metabolic disease and
musculoskeletal inflammation. Curr Opin Pharmacol. 4:281–289. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dut R, Dizdar EA, Birben E, Sackesen C,
Soyer OU, Besler T and Kalayci O: Oxidative stress and its
determinants in the airways of children with asthma. Allergy.
63:1605–1609. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Keaney JF Jr, Larson MG, Vasan RS, Wilson
PW, Lipinska I, Corey D, Massaro JM, Sutherland P, Vita JA and
Benjamin EJ: Framingham Study: Obesity and systemic oxidative
stress: Clinical correlates of oxidative stress in the framingham
study. Arterioscler Thromb Vasc Biol. 23:434–439. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ota C, Baarsma HA, Wagner DE, Hilgendorff
A and Konigshoff M: Linking bronchopulmonary dysplasia to adult
chronic lung diseases: Role of WNT signaling. Mol Cell Pediatr.
3:342016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cui G, Shan L, Hung M, Lei S, Choi I,
Zhang Z, Yu P, Hoi P, Wang Y and Lee SM: A novel Danshensu
derivative confers cardioprotection via PI3K/Akt and Nrf2 pathways.
Int J Cardiol. 168:1349–1359. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lo SC and Hannink M: PGAM5 tethers a
ternary complex containing Keap1 and Nrf2 to mitochondria. Exp Cell
Res. 314:1789–1803. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wicinski M, Malinowski B, Weclewicz MM,
Grzesk E and Grzesk G: Anti-atherogenic properties of resveratrol:
4-week resveratrol administration associated with serum
concentrations of SIRT1, adiponectin, S100A8/A9 and VSMCs
contractility in a rat model. Exp Ther Med. 13:2071–2078. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Aguirre L, Fernandez-Quintela A, Arias N
and Portillo MP: Resveratrol: Anti-obesity mechanisms of action.
Molecules. 19:18632–18655. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Carpene C, Gomez-Zorita S, Deleruyelle S
and Carpene MA: Novel strategies for preventing diabetes and
obesity complications with natural polyphenols. Curr Med Chem.
22:150–164. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bayne K: Revised guide for the care and
use of laboratory animals available. American phaysiological
society. Physiologist. 39:208–211. 1996.
|
|
21
|
Aslani MR, Keyhanmanesh R, Khamaneh AM,
Saadatlou Ebrahimi MA, Abbasi Mesgari M and Alipour MR: Lung
altered expression of il-1β mrna and its signaling pathway
molecules in obese-asthmatic male wistar rats. Iran J Allergy
Asthma Immunol. 15:183–197. 2016.PubMed/NCBI
|
|
22
|
Hariri N and Thibault L: High-fat
diet-induced obesity in animal models. Nutr Res Rev. 23:270–299.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Simson EL and Gold RM: The lee obesity
index vindicated? Physiol Behav. 29:371–376. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Friedewald WT, Levy RI and Fredrickson DS:
Estimation of the concentration of low-density lipoprotein
cholesterol in plasma, without use of the preparative
ultracentrifuge. Clin Chem. 18:499–502. 1972.PubMed/NCBI
|
|
25
|
Shore SA: Obesity and asthma: Lessons from
animal models. J Appl Physiol (1985). 102:516–528. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Alshammari G, Khan R, Brameld J, Amer S
and Lomax MA: Gene expression of inflammatory markers in adipose
tissue between obese women with polycystic ovary and normal obese
women. Eur Rev Med Pharmacol Sci. 21:1099–1105. 2017.PubMed/NCBI
|
|
27
|
Tsuchiya K, Siddiqui S, Risse PA, Hirota N
and Martin JG: The presence of LPS in OVA inhalations affects
airway inflammation and AHR but not remodeling in a rodent model of
asthma. Am J Physiol Lung Cell Mol Physiol. 303:L54–L63. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Turner RS, Thomas RG, Craft S, van Dyck
CH, Mintzer J, Reynolds BA, Brewer JB, Rissman RA, Raman R and
Aisen PS; Alzheimer's Disease Cooperative Study, : A randomized,
double-blind, placebo-controlled trial of resveratrol for Alzheimer
disease. Neurology. 85:1383–1391. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Raj P, Zieroth S and Netticadan T: An
overview of the efficacy of resveratrol in the management of
ischemic heart disease. Ann N Y Acad Sci. 1348:55–67. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ferretta A, Gaballo A, Tanzarella P,
Piccoli C, Capitanio N, Nico B, Annese T, Di Paola M, Dell'aquila
C, De Mari M, et al: Effect of resveratrol on mitochondrial
function: Implications in parkin-associated familiar Parkinson's
disease. Biochim Biophys Acta. 1842:902–915. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chang CC, Lin KY, Peng KY, Day YJ and Hung
LM: Resveratrol exerts anti-obesity effects in high-fat diet obese
mice and displays differential dosage effects on cytotoxicity,
differentiation, and lipolysis in 3T3-L1 cells. Endocr J.
63:169–178. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen J, Zhou H, Wang J, Zhang B, Liu F,
Huang J, Li J, Lin J, Bai J and Liu R: Therapeutic effects of
resveratrol in a mouse model of HDM-induced allergic asthma. Int
Immunopharmacol. 25:43–48. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen S, Zhao X, Ran L, Wan J, Wang X, Qin
Y, Shu F, Gao Y, Yuan L, Zhang Q and Mi M: Resveratrol improves
insulin resistance, glucose and lipid metabolism in patients with
non-alcoholic fatty liver disease: A randomized controlled trial.
Dig Liver Dis. 47:226–232. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xie HC, Han HP, Chen Z and He JP: A study
on the effect of resveratrol on lipid metabolism in hyperlipidemic
mice. Afr J Tradit Complement Altern Med. 11:209–212.
2013.PubMed/NCBI
|
|
35
|
Cochius-den Otter SC, Joosten KF, de
Jongste JC, Hop WC, de Hoog M and Buysse CM: Insulin therapy in
hyperglycemic children with severe acute asthma. J Asthma.
52:681–686. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lugogo NL, Bappanad D and Kraft M:
Obesity, metabolic dysregulation and oxidative stress in asthma.
Biochim Biophys Acta. 1810:1120–1126. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Steffes MW, Gross MD, Lee DH, Schreiner PJ
and Jacobs DR Jr: Adiponectin, visceral fat, oxidative stress, and
early macrovascular disease: The coronary artery risk development
in young adults study. Obesity (Silver Spring). 14:319–326. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ochs-Balcom HM, Grant BJ, Muti P, Sempos
CT, Freudenheim JL, Browne RW, McCann SE, Trevisan M, Cassano PA,
Iacoviello L and Schunemann HJ: Antioxidants, oxidative stress, and
pulmonary function in individuals diagnosed with asthma or COPD.
Eur J Clin Nutr. 60:991–999. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Guo R, Li W, Liu B, Li S, Zhang B and Xu
Y: Resveratrol protects vascular smooth muscle cells against high
glucose-induced oxidative stress and cell proliferation in vitro.
Med Sci Monit Basic Res. 20:82–92. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chen WM, Shaw LH, Chang PJ, Tung SY, Chang
TS, Shen CH, Hsieh YY and Wei KL: Hepatoprotective effect of
resveratrol against ethanol-induced oxidative stress through
induction of superoxide dismutase in vivo and in vitro. Exp Ther
Med. 11:1231–1238. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sood A, Qualls C, Arynchyn A, Beckett WS,
Gross MD, Steffes MW, Smith LJ, Holvoet P, Thyagarajan B and Jacobs
DR Jr: Obesity-asthma association: Is it explained by systemic
oxidant stress? Chest. 136:1055–1062. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang T, Liang X, Abeysekera IR, Iqbal U,
Duan Q, Naha G, Lin L and Yao X: Activation of the Nrf2-Keap 1
pathway in short-term iodide excess in thyroid in rats. Oxid Med
Cell Longev. 2017:43836522017.PubMed/NCBI
|
|
43
|
Wang Z, Ka SO, Lee Y, Park BH and Bae EJ:
Butein induction of HO-1 by p38 MAPK/Nrf2 pathway in adipocytes
attenuates high-fat diet induced adipose hypertrophy in mice. Eur J
Pharmacol. 799:201–210. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li YJ, Kawada T and Azuma A: Nrf2 is a
protective factor against oxidative stresses induced by diesel
exhaust particle in allergic asthma. Oxid Med Cell Longev.
2013:3236072013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Liu H, Wu HY, Wang WY, Zhao ZL, Liu XY and
Wang LY: Regulation of miR-92a on vascular endothelial aging via
mediating Nrf2-KEAP1-ARE signal pathway. Eur Rev Med Pharmacol Sci.
21:2734–2742. 2017.PubMed/NCBI
|
|
46
|
Yang X, Wang D, Ma Y, Xu X, Zhu Z, Wang X,
Deng H, Li C, Chen M, Tong J, et al: Continuous activation of Nrf2
and its target antioxidant enzymes leads to arsenite-induced
malignant transformation of human bronchial epithelial cells.
Toxicol Appl Pharmacol. 289:231–239. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Andre DM, Calixto MC, Sollon C, Alexandre
EC, Leiria LO, Tobar N, Anhe GF and Antunes E: Therapy with
resveratrol attenuates obesity-associated allergic airway
inflammation in mice. Int Immunopharmacol. 38:298–305. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chen B, Lu Y, Chen Y and Cheng J: The role
of Nrf2 in oxidative stress-induced endothelial injuries. J
Endocrinol. 225:R83–R99. 2015. View Article : Google Scholar : PubMed/NCBI
|
